NHS Logo

Antiseizure Medication Interactions (Record no. 101785)

MARC details
000 -LEADER
fixed length control field 04024nam a22004455i 4500
001 - CONTROL NUMBER
control field 978-3-030-82790-8
003 - CONTROL NUMBER IDENTIFIER
control field DE-He213
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20240729134622.0
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr nn 008mamaa
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 220101s2022 sz | s |||| 0|eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
ISBN 9783030827908
-- 978-3-030-82790-8
072 #7 - SUBJECT CATEGORY CODE
Subject category code MJN
Source bicssc
072 #7 - SUBJECT CATEGORY CODE
Subject category code MED056000
Source bisacsh
072 #7 - SUBJECT CATEGORY CODE
Subject category code MKJ
Source thema
100 1# - MAIN ENTRY--PERSONAL NAME
Personal author Patsalos, Philip N.
Relator term author.
Relator code aut
-- http://id.loc.gov/vocabulary/relators/aut
245 10 - TITLE STATEMENT
Title Antiseizure Medication Interactions
Subtitle : A Clinical Guide /
250 ## - EDITION
Edition statement 4th ed. 2022.
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Place of production, publication, distribution, manufacture Cham :
Name of producer, publisher, distributor, manufacturer Springer International Publishing :
-- Imprint: Springer,
Date of production, publication, distribution, manufacture, or copyright notice 2022.
300 ## - PHYSICAL DESCRIPTION
Physical description XV, 357 p. 32 illus.
Other physical details online resource.
336 ## - CONTENT TYPE
Content type term text
Content type code txt
Source rdacontent
337 ## - MEDIA TYPE
Media type term computer
Media type code c
Source rdamedia
338 ## - CARRIER TYPE
Carrier type term online resource
Carrier type code cr
Source rdacarrier
505 0# - CONTENTS
Contents Section 1 - Introduction -- Section 2 - Drug Interactions Between AEDs -- Acetazolamide -- Cannabidiol -- Carbamazepine -- Clobazam -- Clonazepam -- Ethosuximide -- Eslicarbazepine acetate -- Felbamate -- Fenfluramine -- Gabapentin -- Lacosamide -- Lamotrigine -- Levetiraceta -- Methsuximide -- Oxcarbazepine -- Perampanel -- Phenobarbital -- Phenytoin -- Piracetam -- Pregabalin -- Primidone -- Rufinamide -- Stiripentol -- Tiagabine -- Topiramate -- Valproic Acid -- Vigabatrin -- Zonisamide -- Section 3 - Drug Interactions between AEDs and non-AED drugs: Interactions Affecting AEDs -- Acetazolamide -- Cannabidiol -- Carbamazepine -- Clobazam -- Clonazepam -- Ethosuximide -- Eslicarbazepine acetate -- Felbamate -- Fenfluramine -- Gabapentin -- Lacosamide -- Lamotrigine -- Levetiracetam -- Methsuximide -- Oxcarbazepine -- Perampanel -- Phenobarbital -- Phenytoin -- Piracetam -- Pregabalin -- Primidone -- Rufinamide -- Stiripentol -- Tiagabine -- Topiramate -- Valproic Acid -- Vigabatrin -- Zonisamide -- Section 4 - Drug Interactions between AEDs and non-AED drugs: Interactions Affected by AEDS -- Analgesics -- Antimicrobials -- Antineoplastic agents -- Antiulcer drugs -- Cardiovascular drugs -- Immunosuppressants -- Neuromuscular Blocking Agents -- Psychotropic Drugs -- Steroids -- Miscellanea. .
520 ## - ABSTRACT
Abstract This significantly revised fourth edition provides a practically orientated guide to interactions associated with antiseizure medications. It describes pharmacokinetic and pharmacodynamic antiseizure medication (ASM) interactions, including details of the magnitude and mechanism of interactions, and also of drug combinations that are not associated with interactions and therefore can be co-prescribed without undue concern. Presented in alphabetical order and by drug class, drug interactions that occur between ASMs and also between ASMs and non- ASMs are described in three sections: Drug interactions between ASMs; Drug interactions between ASMs and non- ASM Drugs: Interactions affecting ASMs; Drug interactions between ASMs and non ASM Drugs: Interactions affected by ASMs. The latest data on all drug interactions is presented. New agents discussed include cannabidiol, cenobamate, everolimus and fenfluramine,. Antiseizure Medication Interactions: A Clinical Guide, 4th Edition concisely presents the most recent developments and data available on the topic. Therefore, enabling physicians and allied health professionals to make more rational choices when ASM polytherapy regimens are required. It will be of interest to medical professionals in disciplines including neurology, psychiatry and pediatrics. .
650 #0 - SUBJECT HEADINGS
Subject term Neurology .
650 #0 - SUBJECT HEADINGS
Subject term Pharmacology.
9 (RLIN) 7400
650 #0 - SUBJECT HEADINGS
Subject term Psychiatry.
650 14 - SUBJECT HEADINGS
Subject term Neurology.
650 24 - SUBJECT HEADINGS
Subject term Pharmacology.
9 (RLIN) 7400
650 24 - SUBJECT HEADINGS
Subject term Psychiatry.
710 2# - ADDED CORPORATE NAME
Added corporate author SpringerLink (Online service)
856 ## - ONLINE RESOURCE
Uniform Resource Identifier <a href="#gotoholdings">#gotoholdings</a>
Link text Access resource
245 ## - TITLE STATEMENT
Medium [E-Book]
347 ## - DIGITAL FILE CHARACTERISTICS
File type text file
Encoding format PDF
Source rda
912 ## -
-- ZDB-2-SME
912 ## -
-- ZDB-2-SXM
Holdings
Withdrawn status Lost status Damaged status Not for loan Home library Current library Shelving location Date acquired Source of acquisition Total Checkouts Date last seen Uniform Resource Identifier Price effective from Koha item type
        Hillingdon Hospitals Library Services (Hillingdon Hospitals NHS Foundation) Hillingdon Hospitals Library Services (Hillingdon Hospitals NHS Foundation) Online 02/05/2024 Springer BiomedLifeSc   02/05/2024 https://go.openathens.net/redirector/nhs?url=https://doi.org/10.1007/978-3-030-82790-8 02/05/2024 Electronic book
London Health Libraries Consortium Privacy notice and Membership terms and conditions